Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06815679
PHASE2/PHASE3

Physiological Effects of Nebulized Salbutamol in Acute Respiratory Failure Patients on HFNC

Sponsor: Università degli Studi di Ferrara

View on ClinicalTrials.gov

Summary

This is a prospective physiological interventional study that assess the feasibility and safety of administering salbutamol using a vibrating mesh nebulizer during HFNC in patients with acute hypoxemic respiratory failure (AHRF). We evaluate whether this method of salbutamol delivery can reduce inspiratory effort and improve global and regional lung ventilation in AHRF patients. To achieve this, the study will record and analyze the following: esophageal pressure (Pes) curves, global and regional tidal volumes, minute ventilation, and changes in global and regional lung ventilation assessed through Electrical Impedance Tomography (EIT).

Official title: The Physiological Effects of Nebulized Salbutamol in Patients With Acute Respiratory Failure During HFNC

Key Details

Gender

All

Age Range

18 Years - 90 Years

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2025-03-01

Completion Date

2026-07

Last Updated

2025-02-07

Healthy Volunteers

No

Interventions

DRUG

salbutamol 2.5 mg via vibrating mesh nebulizer (VMN)

To evaluate the patient's respiratory effort, the pressure-time product (PTPes) and the delta of Pes oscillations during inspiration (∆ Pes) will be obtained from the analysis of the Pes curve. Global and regional pulmonary tidal volumes will be evaluated with Electrical Impedance Tomography

Locations (1)

Azienda ospedaliera Universitaria di Ferrara

Ferrara, Italy